Shares of Incyte Corp. INCY slid 1.26% to $58.98 Friday, on what proved to be an all-around poor trading session for the ...

Sun Pharmaceutical Industries Ltd. can launch its new hair-loss drug Leqselvi after the Federal Circuit reversed a district ...

The laboratory services company has agreed to purchase certain assets of Incyte's clinical and anatomic pathology testing ...

Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Incyte Corp. v. Sun ...

Incyte (Nasdaq: INCY) announced its participation in the 2025 BofA Securities Health Care Conference. The company’s ...

WILMINGTON, DE — Incyte (Nasdaq: INCY) delivered strong first-quarter financial results for 2025, propelled by revenue growth ...

Just before the May 5 trial date set for Novartis and Incyte to finally hash out their Jakafi royalty dispute in court, the ...

Shares of Incyte Corp. INCY shed 4.03% to $59.61 Tuesday, on what proved to be an all-around rough trading session for the ...

WILMINGTON, Del., May 07, 2025--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 33,413 shares of the Company ...

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Incyte INCY in the ...

Jakafi ® (ruxolitinib) net product revenues of $709 million in Q1'25 (+24% Y/Y); increasing full year 2025 Jakafi guidance to ...

Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 33,413 shares of the Company’s common stock and stock option awards to ...